3D Global Biotech Inc. (TPEX:6808)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
48.30
+0.30 (0.63%)
Dec 31, 2025, 2:59 PM CST
-22.35%
Market Cap3.76B
Revenue (ttm)324.87M
Net Income (ttm)133.88M
Shares Out77.84M
EPS (ttm)1.71
PE Ratio28.28
Forward PEn/a
Dividend0.53 (1.10%)
Ex-Dividend DateJul 7, 2025
Volume61,029
Average Volume259,160
Open48.00
Previous Close48.00
Day's Range47.50 - 49.40
52-Week Range37.55 - 73.50
Beta0.29
RSI54.86
Earnings DateMar 23, 2026

About 3D Global Biotech

3D Global Biotech Inc. develops medical materials for human body reconstruction in China. It uses cell culture systems, 3D printing technology, and bio-inks hydrogel as the basis to develop and produce customized autologous cell-based medical products. The company develops human tissue and organ reconstruction platforms; develops customized and personalized medical equipment; and conducts professional research. It offers artificial bone substitute, skull fixation system, biological dressings, bio inks, and bioprinting equipment, as well as orth... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 43
Stock Exchange Taipei Exchange
Ticker Symbol 6808
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.